Preliminary results about the use of GynEC®-DX in surveillance of patients with Lynch syndrome

R&D activities around GynEC®-DX aim to validate its use in certain clinic profiles for which information cannot be obtained through other techniques. The clinical study led by La Paz hospital (Madrid) aims to validate the use of GynEC®-DX in the biomarkers-guided surveillance of patients with Lynch syndrome. This program has been presented at 33rd National Congress of the Gynecologic Oncology Section of the Spanish Society of Gynecology and Obstetrics (SEGO) hold recently in San Sebastián.

Poster references:

298. Aproximación al diagnóstico molecular del cáncer de endometrio en el síndrome de Lynch.
Rubén García-Abadillo Seivane, Begoña Díaz De la Noval, Alicia Hernández Gutiérrez, Javier De Santiago García, María Dolores Diestro Tejeda.
Hospital Universitario La Paz, Madrid, España.

302. Identificación de pacientes con síndrome de lynch no susceptibles de aplicar un test de diagnóstico molecular para la detección del cáncer de endometrio.
Begoña Díaz De la Noval, Rubén García-Abadillo Seivane, Ignacio Zapardiel Gutiérrez, Javier De Santiago García, María Dolores Diestro Tejeda
Hospital Universitario La Paz, Madrid, España.

See meeting program